|
| |
Tanabe Seiyaku Co., LtdTanabe Seiyaku Co., Ltd. ("the Company"), in consideration of the importance of personal information protection and in order to appropriately protect personal information, strictly observes Japan's Act on the Protection of Personal Information and has formulated and strictly observes its own policies, personal information protection rules, and operational manuals. The Company is committed to the appropriate and safe handling of personal information.
| Contact Details: |
| 7930 Convoy Court |
| San Diego |
| California |
| 92111 |
| United States of America |
| Tel: | 1-858-571-8410 |
| Fax: | 1-858-571-3476 |
| Email: | |
| WWW: | www.tanabe.co.jp/
|
|
Loading...
|
Press Releases on Tanabe Seiyaku Co., Ltd:
|
 |
| ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) |
9th November, 2009 |
ISTA Pharmaceuticals, Inc. |
MIAMI, Nov. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced additional results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5
|
| ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting |
21st October, 2009 |
ISTA Pharmaceuticals, Inc. |
ANAHEIM, Calif., Oct. 21 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate
|
| Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis |
26th June, 2009 |
ISTA Pharmaceuticals, Inc. |
IRVINE, Calif., June 26 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the U.S. Food and Drug
|
| ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis |
1st June, 2009 |
ISTA Pharmaceuticals, Inc. |
IRVINE, Calif., June 1 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it has received notification from the U.S. Food and Drug Administration (FDA) that the
|
| ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium |
22nd January, 2009 |
ISTA Pharmaceuticals, Inc. |
IRVINE, Calif., Jan. 22 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced positive results from the Company's Phase IIb clinical study of ecabet sodium, which
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 744 times since April 2007, the link to the organisation's website has been followed 111 times Recent Search Terms used to find this page: Tanabe Seiyaku jp | tanabe seiyaku co ltd | tanabe seiyaku co ltd | Tanabe Seiyaku Co. Ltd. | tanabe seiyaku | TANABE SEIYAKU | Tanabe Seiyaku Co. Ltd | Tanabe Seiyaku Co. Ltd | tanabe seiyaku co ltd mail | tanabe seiyaku co ltd japan | . Search for more companies in San Diego Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Tanabe Seiyaku Co., Ltd |
